Article Text

Download PDFPDF
Rare disease
SAPHO syndrome with bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer
  1. Katsuhiko Matsumaru1,
  2. Kazuki Nagai1,
  3. Takayuki Murakami2,
  4. Kazuo Andoh3
  1. 1Department of Internal Medicine, Nagai Clinic, Yokohama, Japan
  2. 2Department of Urology, Yokohama Minamikyousai Hospital, Yokohama, Japan
  3. 3Department of Radiology, Saiseikai Yokohama-Shi Nanbu Hospital, Yokohama, Japan
  1. Correspondence to Katsuhiko Matsumaru, matsuckkid{at}yahoo.co.jp

Summary

The authors describe a case of SAPHO syndrome with bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer. The patient had undergone transurethral resection (TUR) and was treated with BCG immunotherapy following TUR. Two years after treatment for bladder cancer, the patient had palmoplantar pustulosis, and in the past 1 month suffered from pain localised to the anterior chest wall. The bone scintigraphy showed a strong focal enrichment in the right chest wall, suggesting spondyloarthropathy rather than malignant disease. On the basis of clinical and scintigraphy findings, SAPHO syndrome was diagnosed. The patient was treated with topical therapy and non-steroidal anti-inflammatory drugs and symptoms improved. The authors suggest that SAPHO syndrome might be caused by an association with BCG immunotherapy.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.